Inactive Instrument

Global WholeHealth Partners Corporation Stock Other OTC

Equities

GWHP

US37959N1028

Medical Equipment, Supplies & Distribution

Sales 2021 0.04 Sales 2022 0.01 Capitalization 1.22M
Net income 2021 -9M Net income 2022 -5M EV / Sales 2021 675,205,295 x
Net Debt 2021 0.06 Net Debt 2022 0.69 EV / Sales 2022 165,700,840 x
P/E ratio 2021
-2.52 x
P/E ratio 2022
-0.19 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 89.69%
More Fundamentals * Assessed data
Dynamic Chart
Global WholeHealth Partners Corporation Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Global WholeHealth Partners Corporation Auditor Raises 'Going Concern' Doubt CI
Global WholeHealth Partners Corporation Announces Executive Changes CI
Global WholeHealth Partners Corporation Announces Appointment of F. Rene Alvarez, Jr. as Chief Executive Officer CI
Global WholeHealth Partners Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022 CI
Global Wholehealth Partners Corporation Announces Board and Executive Changes CI
Global WholeHealth Partners Corporation Accepts Resignation of Charles Strongo as Chief Executive Officer CI
Global WholeHealth Partners Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021 CI
Global WholeHealth Partners Corporation Declares Special Common Stock Dividend, Payable on April 1, 2022 CI
Global WholeHealth Partners Corporation Reports Earnings Results for the First Quarter Ended September 30, 2021 CI
Global WholeHealth Partners Signs a Binding MOU With Pan Probe Biotech and AvantGen to Develop the Newest COVID-19 Antigen Test on the Market CI
Global WholeHealth Partners Corp Partners With Pan Probe Biotech and AvantGen to Develop the Newest COVID19 Antigen Test on the Market CI
Global Wholehealth Partners Corporation Reports Earnings Results for the Full Year Ended June 30, 2021 CI
Global WholeHealth Partners Corporation Auditor Raises 'Going Concern' Doubt CI
Global WholeHealth Partners Corp Now Able to Sell Through Shopify’s Multibillion Dollar Online Platform CI
More news
Managers TitleAgeSince
Chief Executive Officer 85 19-07-31
Director/Board Member 59 22-07-26
Members of the board TitleAgeSince
Chief Executive Officer 85 19-07-31
Director/Board Member 59 22-07-26
More insiders
Global WholeHealth Partners Corporation develops and markets in-vitro diagnostic tests for over the counter (OTC), or consumer-use and point-of-care (POC), which includes hospitals, physicians’ offices and medical clinics, including those within penal systems throughout the United States and abroad. The Company markets a range of diagnostic test kits for consumer use through OTC sales, and for use by health care professionals, generally located at medical clinics, physician offices and hospitals known as POC, in the United States. These test kits are known as in-vitro diagnostic test kits or IVD products. The Company has its manufacturing, warehousing and laboratories in San Diego and Escondido, California.
More about the company